{
  "ticker": "GILD",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T08:46:13.654982",
  "count": 133,
  "transactions": [
    {
      "id": 13074,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 13077,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 13079,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 13083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 13085,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 13089,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 25650,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 25654,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 25656,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 25660,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 25663,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 25667,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 41962,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 41969,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 41973,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 41978,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 41982,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 41988,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 61281,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 61289,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 61294,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 61302,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 61308,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 61314,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 82873,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 82881,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 82886,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 82896,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 82902,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 82908,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 106812,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 106820,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 106825,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 106835,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 106843,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 106849,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 132713,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 132723,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 132729,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 132744,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 132753,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 132759,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 160574,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 160584,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 160591,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 160607,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 160616,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 160622,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 190808,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 190819,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 190826,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 190842,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 190853,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 190859,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 13087,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 25665,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 41986,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 61312,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 82906,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 106847,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 132757,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 160620,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 190857,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 3948,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 13075,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 25651,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 41964,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 61283,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 82875,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 106814,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 132715,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 160576,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 190810,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 3949,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 3951,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 3952,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 3953,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 3954,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 13076,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 13080,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 13081,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 13082,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 13084,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 25653,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 25657,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 25658,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 25659,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 25662,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 41968,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 41974,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 41976,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 41977,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 41981,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 61288,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 61295,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 61299,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 61300,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 61307,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 82880,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 82887,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 82892,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 82893,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 82901,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 106819,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 106826,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 106831,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 106832,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 106841,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 132722,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 132730,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 132737,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 132738,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 132751,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 160583,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 160592,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 160599,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 160600,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 160614,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 190818,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 190827,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 190834,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 190835,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 190851,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 3950,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 13078,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 25655,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 41970,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 61291,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 82883,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 106822,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 132725,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 160586,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 190821,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    }
  ]
}